Publicacións en colaboración con investigadores/as de Leiden University Medical Center (9)

2023

  1. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas

    Clinical Epigenetics, Vol. 15, Núm. 1

2022

  1. Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 74, Núm. 6, pp. 972-983

2021

  1. Assessment of assumptions of statistical analysis methods in randomised clinical trials: The what and how

    BMJ Evidence-Based Medicine, Vol. 26, Núm. 3, pp. 121-126

2020

  1. Comparison of bisulfite pyrosequencing and methylation-specific qPCR for methylation assessment

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-13

2019

  1. Assessing assumptions for statistical analyses in randomised clinical trials

    BMJ Evidence-Based Medicine, Vol. 24, Núm. 5, pp. 185-189

  2. Methylation assessment for the prediction of malignancy in mediastinal adenopathies obtained by endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer

    Cancers, Vol. 11, Núm. 10

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

2017

  1. Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units

    Scientific Reports, Vol. 7

2016

  1. Methods for testing the Markov condition in the illness–death model: a comparative study

    Statistics in Medicine, Vol. 35, Núm. 20, pp. 3549-3562